Siemens Files PMA For Digital Breast Tomosynthesis
Published: Jun 27, 2014
MALVERN, Pa.--(BUSINESS WIRE)--Siemens Healthcare has announced that it recently submitted to the U.S. Food and Drug Administration (FDA) its premarket approval application (PMA) for the MAMMOMAT Inspiration® with Breast Tomosynthesis option.
Help employers find you! Check out all the jobs and post your resume.